Millennium Management’s Spruce Biosciences SPRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.31M Buy
+111,888
New +$7.72M ﹤0.01% 2517
2024
Q2
Sell
-1,363
Closed -$80.3K 6668
2024
Q1
$80.3K Sell
1,363
-5,443
-80% -$1.38M ﹤0.01% 5617
2023
Q4
$1.5M Sell
6,806
-974
-13% -$113K ﹤0.01% 3839
2023
Q3
$1.32M Buy
7,780
+78
+1% +$13.1K ﹤0.01% 3957
2023
Q2
$1.24M Sell
7,702
-416
-5% -$69.6K ﹤0.01% 3866
2023
Q1
$1.35M Buy
8,118
+6,151
+313% +$1.14M ﹤0.01% 3814
2022
Q4
$162K Buy
1,967
+33
+2% +$2.76K ﹤0.01% 5409
2022
Q3
$199K Sell
1,934
-601
-24% -$84K ﹤0.01% 5670
2022
Q2
$331K Buy
+2,535
New +$325K ﹤0.01% 5289
2021
Q4
Sell
-515
Closed -$232K 7488
2021
Q3
$232K Buy
515
+285
+124% +$179K ﹤0.01% 6014
2021
Q2
$193K Sell
230
-744
-76% -$794K ﹤0.01% 6035
2021
Q1
$1.21M Sell
974
-689
-41% -$1.06M ﹤0.01% 4022
2020
Q4
$3.03M Buy
+1,663
New +$2.76M ﹤0.01% 2887

Other funds holding SPRB

Millennium Management's SPRB Position: Q1 2026 in Review

Millennium Management opened a new position in Spruce Biosciences (SPRB) in Q1 2026: 111,888 shares worth $7.31M. The stake represents ﹤0.01% of the portfolio and ranks #2517 among its holdings. This is a return to the name: Millennium Management previously reported a position in SPRB as recently as Q1 2024.

Millennium Management first reported a position in SPRB in Q4 2020 and has held it in 13 quarters since. 32 funds tracked by Wall St. Rank hold SPRB as of Q1 2026.

  • Millennium Management held 111,888 shares of Spruce Biosciences worth $7.31M as of Q1 2026.
  • Spruce Biosciences was a new Millennium Management position in Q1 2026.
  • Spruce Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2517 holding.
  • Millennium Management first reported a position in Spruce Biosciences in Q4 2020 and has held it in 13 quarters since.
  • 32 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.